Skip to main content
. 2023 Mar 24;44(8):2781–2786. doi: 10.1007/s10072-023-06753-5

Table 4.

Prevalence estimates in patients who were not tracheostomized at the prevalence date

People who did not undergo tracheostomy at prevalence date Prevalence on January 1 2015 Prevalence on January 1 2019 Rate ratio 2019/2015 (95% confidence interval), p
Overall population
Study population (n) 963,329 928,460 1.09 (0.84–1.41), 0.50
Prevalent cases (n) 121 124
Prevalence rate (× 100,000 person) [95% confidence interval] 12.56 (10.42–15.01) 13.36 (11.11–15.92)
Women
Study population (n) [%] 497,585 472,818 1.15 (0.75–1.77), 0.51
Prevalent cases (n) 44 48
Prevalence rate (× 100,000 person) [95% confidence interval] 8.84 (6.42–11.87) 10.15 (7.49–13.46
Men
Study population (n) [%] 465,744 455,282 1.0 (0.73–1.43), 0.95
Prevalent cases (n) 77 76
Prevalence rate (× 100,000 person) [95% confidence interval] 16.53 (13.05–20.66) 16.69 (13.15–20.89)
People aged ≥ 65 years at prevalence date
Study population (n) [%] 207,377 225,814 0.81 (0.57–1.14), 0.21
Prevalent cases (n) 76 67
Prevalence rate (× 100,000 person) [95% confidence interval] 36.65 (28.87–45.87) 29.67 (22.99–37.68)
People aged < 65 years at prevalence date
Study population (n) [%] 755,952 702,646 1.32 (0.90–2.06), 0.12
Prevalent cases (n) 45 57
Prevalence rate (× 100,000 person) [95% confidence interval] 5.95 (4.34–7.96) 8.11 (6.14–10.51)
People who undervent PEG alone
Study population (n) [%] 963,329 928,460 1.56 (0.56–0.39), 0.34
Prevalent cases (n) 8 12
Prevalence rate (× 100,000 person) [95% confidence interval] 0.83 (0.36–1.63) 1.29 (0.67–2.26)